T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNR
926
Core Natural Resources Inc
CNR
$4.64B
| $22.3M | ﹤0.01% |
289,124
+19,267
| +7% | +$1.63M |
|
927
Tarsus Pharmaceuticals
TARS
$3.02B
| $22.3M | ﹤0.01% |
433,171
-27,602
| -6% | -$1.36M |
|
928
Gulfport Energy Corp
GPOR
$3.01B
| $22.2M | ﹤0.01% |
120,414
-11,062
| -8% | -$2.01M |
|
|
SPNS
929
DELISTED
Sapiens International
SPNS
| $22.2M | ﹤0.01% |
817,998
+1,176
| +0.1% | +$31.7K |
|
930
Alcoa
AA
$13.1B
| $22.2M | ﹤0.01% |
726,288
+173,243
| +31% | +$6.07M |
|
931
Masco
MAS
$14.7B
| $21.9M | ﹤0.01% |
315,610
-1,325
| -0.4% | -$99.2K |
|
932
Photronics
PLAB
$1.97B
| $21.5M | ﹤0.01% |
1,035,812
+2,122
| +0.2% | +$47.3K |
|
933
Jacobs Solutions
J
$16.8B
| $21.4M | ﹤0.01% |
179,047
+379
| +0.2% | +$48.8K |
|
934
Qualys
QLYS
$6.78B
| $21.4M | ﹤0.01% |
170,135
+1,426
| +0.8% | +$193K |
|
|
KMTS
935
Kestra Medical Technologies
KMTS
$1.63B
| $21.2M | ﹤0.01% |
+849,418
| New | +$19.5M |
|
936
Aptiv
APTV
$10.2B
| $21.1M | ﹤0.01% |
354,954
-108
| -0% | -$6.85K |
|
937
Hilton Grand Vacations
HGV
$3.49B
| $21.1M | ﹤0.01% |
564,130
+4,716
| +0.8% | +$188K |
|
938
iShares Core S&P 500 ETF
IVV
$910B
| $20.8M | ﹤0.01% |
37,019
-9,520
| -20% | -$5.62M |
|
939
Best Buy
BBY
$18B
| $20.7M | ﹤0.01% |
280,800
+2,758
| +1% | +$227K |
|
940
Immunome
IMNM
$3B
| $20.7M | ﹤0.01% |
3,069,607
+786,853
| +34% | +$7.55M |
|
941
CI&T Inc
CINT
$474M
| $20.6M | ﹤0.01% |
3,443,533
-414,460
| -11% | -$2.78M |
|
942
Healthpeak Properties
DOC
$14.3B
| $20.5M | ﹤0.01% |
1,014,594
+20,797
| +2% | +$421K |
|
943
Interparfums
IPAR
$3.7B
| $20.5M | ﹤0.01% |
179,847
+43,709
| +32% | +$5.8M |
|
944
Core & Main
CNM
$8.64B
| $20.5M | ﹤0.01% |
423,646
-20,373
| -5% | -$1.06M |
|
945
Rocket Pharmaceuticals
RCKT
$367M
| $20.3M | ﹤0.01% |
3,043,682
-104,838
| -3% | -$1.04M |
|
946
Pentair
PNR
$10.7B
| $20.3M | ﹤0.01% |
231,586
+3,123
| +1% | +$298K |
|
947
Vital Farms
VITL
$498M
| $20.2M | ﹤0.01% |
662,058
-116
| -0% | -$4.17K |
|
948
Impinj
PI
$5.46B
| $20.1M | ﹤0.01% |
221,725
+2,644
| +1% | +$296K |
|
949
Molson Coors Class B
TAP
$7.85B
| $20.1M | ﹤0.01% |
329,963
-40,727
| -11% | -$2.35M |
|
950
Invesco Senior Loan ETF
BKLN
$6.76B
| $19.7M | ﹤0.01% |
950,000
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.